Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Protara Therapeutics, Inc. | 24,000 | reported | 12 Jun 2025 | tx 6+84,000 |
| Prelude Therapeutics Inc | 18,750 | reported | 04 Oct 2025 | tx 37+1,285,000−156,833 |
| BeOne Medicines Ltd. | 0 | reported | 14 Dec 2021 | tx 300+5,125,022−1,120,049 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Oct 2025 | EXERCISE | Prelude Therapeutics Inc | 9,375 | — | |
| 04 Oct 2025 | TAX_WITHHOLDING | Prelude Therapeutics Inc | 3,355 | 1.47 USD | |
| 04 Oct 2025 | EXERCISE | Prelude Therapeutics Inc | 9,375 | 0.00 USD | deriv |
| 04 Jul 2025 | EXERCISE | Prelude Therapeutics Inc | 9,375 | — | |
| 04 Jul 2025 | TAX_WITHHOLDING | Prelude Therapeutics Inc | 3,355 | 0.79 USD | |
| 04 Jul 2025 | EXERCISE | Prelude Therapeutics Inc | 9,375 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Protara Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 04 Apr 2025 | TAX_WITHHOLDING | Prelude Therapeutics Inc | 3,355 | 0.68 USD | |
| 04 Apr 2025 | EXERCISE | Prelude Therapeutics Inc | 9,375 | — | |
| 04 Apr 2025 | EXERCISE | Prelude Therapeutics Inc | 9,375 | 0.00 USD | deriv |
| 04 Feb 2025 | GRANT_AWARD | Prelude Therapeutics Inc | 200,000 | 0.00 USD | deriv |
| 04 Jan 2025 | EXERCISE | Prelude Therapeutics Inc | 9,375 | — | |
| 04 Jan 2025 | TAX_WITHHOLDING | Prelude Therapeutics Inc | 3,859 | 1.39 USD | |
| 04 Jan 2025 | EXERCISE | Prelude Therapeutics Inc | 9,375 | 0.00 USD | deriv |
| 04 Oct 2024 | TAX_WITHHOLDING | Prelude Therapeutics Inc | 3,349 | 2.00 USD | |
| 04 Oct 2024 | EXERCISE | Prelude Therapeutics Inc | 9,375 | — | |
| 04 Oct 2024 | EXERCISE | Prelude Therapeutics Inc | 9,375 | 0.00 USD | deriv |
| 04 Jul 2024 | EXERCISE | Prelude Therapeutics Inc | 9,375 | — | |
| 04 Jul 2024 | TAX_WITHHOLDING | Prelude Therapeutics Inc | 3,347 | 3.60 USD | |
| 04 Jul 2024 | EXERCISE | Prelude Therapeutics Inc | 9,375 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Protara Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 04 Apr 2024 | EXERCISE | Prelude Therapeutics Inc | 9,375 | — | |
| 04 Apr 2024 | TAX_WITHHOLDING | Prelude Therapeutics Inc | 3,347 | 4.74 USD | |
| 04 Apr 2024 | EXERCISE | Prelude Therapeutics Inc | 9,375 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Prelude Therapeutics Inc | 175,000 | 0.00 USD | deriv |